Treatments for primary delusional infestation

Cochrane Database Syst Rev. 2019 Dec 10;12(12):CD011326. doi: 10.1002/14651858.CD011326.pub2.

Abstract

Background: Primary delusional infestation (DI) is a primary psychiatric disorder characterised by delusions and abnormal tactile sensations. The pathophysiology is undecided and treatment includes both pharmacological and non-pharmacological options. There is currently no Cochrane Review of the treatments used. Primary DI is a diagnosis often encountered by both dermatologists and psychiatrists, with a large associated disease burden.

Objectives: To evaluate the effectiveness of different treatments in primary delusional infestation (DI).

Search methods: On 24 December 2014 and 19 March 2019, we searched the Cochrane Schizophrenia Group's Study-Based Register of Trials including registries of clinical trials.

Selection criteria: Randomised controlled trials involving the treatment of adults with primary DI.

Data collection and analysis: Two review authors independently screened and assessed studies for inclusion using pre-specified inclusion criteria.

Main results: We did not identify any studies for inclusion.

Authors' conclusions: Currently there is no evidence from RCTs available to compare treatment of primary DI with placebo. We cannot, therefore, make any conclusions regarding the effects of treatments (pharmacological or non-pharmacological) for primary DI. This lack of evidence for treatment of primary DI has implications for research and practice. Robust randomised trials are indicated.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Humans
  • Psychotherapy*
  • Randomized Controlled Trials as Topic
  • Schizophrenia, Paranoid / therapy*
  • Self Concept

Substances

  • Antipsychotic Agents